Live Feeds

Source map — Vera kidney drug Trutakna shows strong final results in Phase 3 trial

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
STAT news 60%
markets.businessinsider.com news 60%
HCPLive news 60%
Yahoo Finance news 60%
FirstWord Pharma news 60%
Investor's Business Daily news 60%
www.erome.com news 50%
www.rttnews.com news 50%
www.pornhub.com news 50%
www.xvideos.com news 50%
www.marketscreener.com news 50%
www.clinicaltrialvanguard.com news 50%
help.naver.com news 50%
en.wikipedia.org news 50%
secure.vera.com news 50%
www.verahealth.ai news 50%
www.youtube.com news 50%
www.justwatch.com news 50%
wb.vera.com news 50%
www.drugtopics.com news 50%
ir.veratx.com social 50%
trial.medpath.com news 50%
www.manilatimes.net news 50%
www.financialcontent.com news 50%
www.nbcnews.com news 50%
news.qq.com news 50%
www.trialfriend.com news 50%
www.hcplive.com news 50%
www.cancernetwork.com news 50%
ctv.veeva.com news 50%
stockanalysis.com news 50%
www.marketbeat.com news 50%
simplywall.st news 50%
pro.thestreet.com news 50%
finance.yahoo.com news 50%
www.empr.com news 50%
www.statnews.com news 50%
pulse2.com news 50%